About Mankind Pharma Limited (MANKIND)
Mankind Pharma Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector.
MANKIND trades on the Indian stock exchanges (NSE/BSE) and is classified as a large-cap stock .
Key Statistics
- Current Price
- ₹1,998.50
- Market Cap
- ₹825.04B
- 52-Week High
- ₹2,716.50
- 52-Week Low
- ₹1,909.70
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
₹1,000 Invested in Mankind Pharma Limited (MANKIND)
How much would ₹1,000 invested in MANKIND be worth today?
What would ₹1,000 invested in MANKIND 1 year ago be worth today?
A ₹1,000 investment in Mankind Pharma Limited (MANKIND) in 2025 would be worth ₹832 as of May 2026, representing a -16.8% total return.
What would ₹1,000 invested in MANKIND at IPO be worth today?
A ₹1,000 investment in Mankind Pharma Limited (MANKIND) at IPO would be worth ₹1,406 as of May 2026, representing a +40.6% total return.
Monthly Returns Heatmap
Over the past 2+ years (35 months), Mankind Pharma Limited (MANKIND) has averaged a monthly return of +1.42% with a median return of +0.10%. The stock had 18 positive months (51%) and 17 negative months (49%). The best month in MANKIND's history was June 2023 with a +25.5% return, while the worst was January 2025 at -15.4%. Historically, August tends to be the strongest month (averaging +7.5%), and January the weakest (-6.0%).
MANKIND's longest winning streak was 6 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2024 with a cumulative return of +41.7%, and the worst was 2025 at -24.4%.
Annual Returns
Over 3 years of trading history, Mankind Pharma Limited (MANKIND) has delivered an average annual return of +4.19% with a median return of -9.01%. The compound annual growth rate (CAGR) is +0.28%. The stock posted gains in 1 years (33%) and losses in 2 years (67%).
MANKIND's best year was 2024 with a +45.29% gain, while the worst was 2025 at -23.71%. The longest streak of consecutive positive years was 1, and the longest losing streak was 2 years. MANKIND achieved double-digit gains (10%+) in 1 years. It suffered double-digit losses in 1 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -9.01% | ₹2,196.50 | ₹1,998.50 |
| 2025 | -23.71% | ₹2,879.26 | ₹2,196.50 |
| 2024 | +45.29% | ₹1,981.72 | ₹2,879.26 |
Frequently Asked Questions: MANKIND
What sector is MANKIND in? ▼
MANKIND operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has MANKIND performed historically? ▼
Over 3 years of trading history, MANKIND has posted gains in 1 years (33% of the time). The best year was 2024 with a +45.3% return. Past performance does not guarantee future results.
How can I invest in MANKIND? ▼
You can invest in MANKIND through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold MANKIND.
Last updated: 4/4/2026